Trial
NCT02283359
Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
—
Condition
Esophageal Cancer
Intervention
Selinexor
Why stopped
Principal Investigator left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-15